Client: HRA Pharma
Access to contraception in the UK has been affected by budget cuts,
fragmented services and reduced GP opening times, a situation that worsened during the pandemic.
HRA Pharma tasked Brands2Life with launching Hana, the first contraceptive pill available OTC,
making it a landmark moment in the history of women's health. We delivered a bold campaign that
generated over 740 balanced media stories, with the potential reach of over 15 billion. We drove over
14,000 people to the Hana website generating £6.5k in sales and the brand secured 95% market
share, positioning HRA Pharma as the leader of this new category.